BNP Paribas Financial Markets’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,077
Closed -$75K 3511
2024
Q1
$75K Buy
5,077
+2,043
+67% +$30.2K ﹤0.01% 2837
2023
Q4
$40.7K Buy
3,034
+1,495
+97% +$20K ﹤0.01% 2881
2023
Q3
$19K Sell
1,539
-1,187
-44% -$14.6K ﹤0.01% 2891
2023
Q2
$33.5K Buy
+2,726
New +$33.5K ﹤0.01% 2924
2021
Q1
Sell
-5
Closed -$34 3516
2020
Q4
$34 Hold
5
﹤0.01% 3430
2020
Q3
$20 Hold
5
﹤0.01% 3528
2020
Q2
$17 Hold
5
﹤0.01% 3628
2020
Q1
$11 Hold
5
﹤0.01% 3663
2019
Q4
$16 Sell
5
-159
-97% -$509 ﹤0.01% 3712
2019
Q3
$738 Sell
164
-44
-21% -$198 ﹤0.01% 3765
2019
Q2
$992 Hold
208
﹤0.01% 3741
2019
Q1
$1.14K Hold
208
﹤0.01% 3552
2018
Q4
$633 Buy
208
+39
+23% +$119 ﹤0.01% 3301
2018
Q3
$709 Hold
169
﹤0.01% 3660
2018
Q2
$653 Sell
169
-3,254
-95% -$12.6K ﹤0.01% 3663
2018
Q1
$21.7K Buy
3,423
+40
+1% +$253 ﹤0.01% 3323
2017
Q4
$27.3K Buy
3,383
+1,705
+102% +$13.8K ﹤0.01% 3232
2017
Q3
$19.2K Sell
1,678
-115
-6% -$1.32K ﹤0.01% 3091
2017
Q2
$17.5K Buy
1,793
+1,484
+480% +$14.5K ﹤0.01% 3186
2017
Q1
$7.48K Sell
309
-785
-72% -$19K ﹤0.01% 2686
2016
Q4
$35.1K Sell
1,094
-197
-15% -$6.33K ﹤0.01% 2514
2016
Q3
$64.5K Buy
1,291
+689
+114% +$34.4K ﹤0.01% 2319
2016
Q2
$25.5K Buy
+602
New +$25.5K ﹤0.01% 2500
2016
Q1
Sell
-3,201
Closed -$199K 3420
2015
Q4
$199K Buy
3,201
+290
+10% +$18K ﹤0.01% 1928
2015
Q3
$195K Buy
2,911
+1,748
+150% +$117K ﹤0.01% 1970
2015
Q2
$113K Buy
1,163
+867
+293% +$84.3K ﹤0.01% 2023
2015
Q1
$27.6K Buy
+296
New +$27.6K ﹤0.01% 2212
2014
Q4
Sell
-749
Closed -$51.7K 3276
2014
Q3
$51.7K Buy
749
+714
+2,040% +$49.3K ﹤0.01% 2155
2014
Q2
$2K Sell
35
-124
-78% -$7.08K ﹤0.01% 2625
2014
Q1
$5.5K Hold
159
﹤0.01% 1974
2013
Q4
$6.69K Sell
159
-3,151
-95% -$133K ﹤0.01% 2430
2013
Q3
$98.7K Sell
3,310
-1,297
-28% -$38.7K ﹤0.01% 2096
2013
Q2
$244K Buy
+4,607
New +$244K ﹤0.01% 1858